- Home
- QIPT vs GNTA Comparison
QIPT vs GNTA Comparison
Compare QIPT & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QIPT
- GNTA
- Stock Information
- Founded
- QIPT 1993
- GNTA 2014
- Country
- QIPT United States
- GNTA Italy
- Employees
- QIPT N/A
- GNTA N/A
- Industry
- QIPT
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QIPT
- GNTA Health Care
- Exchange
- QIPT Nasdaq
- GNTA Nasdaq
- Market Cap
- QIPT 92.2M
- GNTA 81.2M
- IPO Year
- QIPT N/A
- GNTA 2021
- Fundamental
- Price
- QIPT $2.07
- GNTA $4.00
- Analyst Decision
- QIPT Buy
- GNTA Strong Buy
- Analyst Count
- QIPT 2
- GNTA 1
- Target Price
- QIPT $2.85
- GNTA $25.00
- AVG Volume (30 Days)
- QIPT 2.6M
- GNTA 5.2K
- Earning Date
- QIPT 05-12-2025
- GNTA 01-01-0001
- Dividend Yield
- QIPT N/A
- GNTA N/A
- EPS Growth
- QIPT N/A
- GNTA N/A
- EPS
- QIPT N/A
- GNTA N/A
- Revenue
- QIPT $240,848,000.00
- GNTA N/A
- Revenue This Year
- QIPT $3.35
- GNTA N/A
- Revenue Next Year
- QIPT $5.39
- GNTA N/A
- P/E Ratio
- QIPT N/A
- GNTA N/A
- Revenue Growth
- QIPT N/A
- GNTA N/A
- 52 Week Low
- QIPT $1.35
- GNTA $2.79
- 52 Week High
- QIPT $4.07
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- QIPT 54.67
- GNTA 41.68
- Support Level
- QIPT $1.89
- GNTA $3.80
- Resistance Level
- QIPT $2.21
- GNTA $6.12
- Average True Range (ATR)
- QIPT 0.16
- GNTA 0.41
- MACD
- QIPT 0.05
- GNTA -0.06
- Stochastic Oscillator
- QIPT 73.58
- GNTA 8.62
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.